221 related articles for article (PubMed ID: 27494903)
61. Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis.
Bezzerri V; Avitabile C; Dechecchi MC; Lampronti I; Borgatti M; Montagner G; Cabrini G; Gambari R; Romanelli A
J Pept Sci; 2014 Oct; 20(10):822-30. PubMed ID: 25201563
[TBL] [Abstract][Full Text] [Related]
62. Design, synthesis and biological evaluation of simplified side chains of the macrolide antibiotic etnangien.
Altendorfer M; Irschik H; Menche D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5731-4. PubMed ID: 22832317
[TBL] [Abstract][Full Text] [Related]
63. In vitro activities of macrolides against gram-positive aerobes, Haemophilus influenzae, Moraxella catarrhalis and Bacteroides fragilis in Taiwan.
Wang FD; Liu IM; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Apr; 62(4):230-5. PubMed ID: 10367484
[TBL] [Abstract][Full Text] [Related]
64. MM 46115, a new antiviral antibiotic from Actinomadura pelletieri. Characteristics of the producing cultures, fermentation, isolation, physico-chemical and biological properties.
Ashton RJ; Kenig MD; Luk K; Planterose DN; Scott-Wood G
J Antibiot (Tokyo); 1990 Nov; 43(11):1387-93. PubMed ID: 2177052
[TBL] [Abstract][Full Text] [Related]
65. Antibacterial properties of sophorolipid-modified gold surfaces against Gram positive and Gram negative pathogens.
Valotteau C; Banat IM; Mitchell CA; Lydon H; Marchant R; Babonneau F; Pradier CM; Baccile N; Humblot V
Colloids Surf B Biointerfaces; 2017 Sep; 157():325-334. PubMed ID: 28609707
[TBL] [Abstract][Full Text] [Related]
66. The thuggacins, novel antibacterial macrolides from Sorangium cellulosum acting against selected Gram-positive bacteria.
Irschik H; Reichenbach H; Höfle G; Jansen R
J Antibiot (Tokyo); 2007 Dec; 60(12):733-8. PubMed ID: 18276996
[TBL] [Abstract][Full Text] [Related]
67. Macrolides in cystic fibrosis.
Bell SC; Senini SL; McCormack JG
Chron Respir Dis; 2005; 2(2):85-98. PubMed ID: 16279156
[TBL] [Abstract][Full Text] [Related]
68. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
King P
Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
[TBL] [Abstract][Full Text] [Related]
69. Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons.
Gielen V; Sykes A; Zhu J; Chan B; Macintyre J; Regamey N; Kieninger E; Gupta A; Shoemark A; Bossley C; Davies J; Saglani S; Walker P; Nicholson SE; Dalpke AH; Kon OM; Bush A; Johnston SL; Edwards MR
J Allergy Clin Immunol; 2015 Jul; 136(1):177-188.e11. PubMed ID: 25630941
[TBL] [Abstract][Full Text] [Related]
70. New Bicyclic Azalide Macrolides Obtained by Tandem Palladium Catalyzed Allylic Alkylation/Conjugated Addition Reaction.
Alihodžić S; Čipčić Paljetak H; Čikoš A; Elenkov IJ
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056746
[TBL] [Abstract][Full Text] [Related]
71. Synthesis and in vitro antibacterial activities of 3-thiazol-4-yl-1-carba-1-dethiacephalosporins.
Hornback WJ; Munroe JE; Counter FT
J Antibiot (Tokyo); 1994 Sep; 47(9):1052-64. PubMed ID: 7928693
[TBL] [Abstract][Full Text] [Related]
72. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
Bush A
Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
[TBL] [Abstract][Full Text] [Related]
73. In vitro antibacterial effects of statins against bacterial pathogens causing skin infections.
Ko HHT; Lareu RR; Dix BR; Hughes JD
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1125-1135. PubMed ID: 29569046
[TBL] [Abstract][Full Text] [Related]
74. A new series of macrolide derivatives with 4''-O-saccharide substituents.
Xu P; Chen XZ; Liu L; Jin ZP; Lei PS
Bioorg Med Chem Lett; 2010 Sep; 20(18):5527-31. PubMed ID: 20716487
[TBL] [Abstract][Full Text] [Related]
75. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).
Mendes C; Marin ME; Quiñones F; Sifuentes-Osornio J; Siller CC; Castanheira M; Zoccoli CM; López H; Súcari A; Rossi F; Angulo GB; Segura AJ; Starling C; Mimica I; Felmingham D
Braz J Infect Dis; 2003 Feb; 7(1):44-61. PubMed ID: 12807691
[TBL] [Abstract][Full Text] [Related]
76. Interferon-gamma enhances rhinovirus-induced RANTES secretion by airway epithelial cells.
Konno S; Grindle KA; Lee WM; Schroth MK; Mosser AG; Brockman-Schneider RA; Busse WW; Gern JE
Am J Respir Cell Mol Biol; 2002 May; 26(5):594-601. PubMed ID: 11970912
[TBL] [Abstract][Full Text] [Related]
77.
Nakamoto K; Watanabe M; Sada M; Inui T; Nakamura M; Honda K; Wada H; Ishii H; Takizawa H
Exp Lung Res; 2019 Oct; 45(8):255-266. PubMed ID: 31517562
[No Abstract] [Full Text] [Related]
78. Genetic Adaptation and Acquisition of Macrolide Resistance in Haemophilus spp. during Persistent Respiratory Tract Colonization in Chronic Obstructive Pulmonary Disease (COPD) Patients Receiving Long-Term Azithromycin Treatment.
Carrera-Salinas A; González-Díaz A; Ehrlich RL; Berbel D; Tubau F; Pomares X; Garmendia J; Domínguez MÁ; Ardanuy C; Huertas D; Marín A; Montón C; Mell JC; Santos S; Marti S
Microbiol Spectr; 2023 Feb; 11(1):e0386022. PubMed ID: 36475849
[TBL] [Abstract][Full Text] [Related]
79. Synthesis, Structural Reassignment, and Antibacterial Evaluation of 2,18-Seco-Lankacidinol B.
Yao Y; Cai L; Seiple IB
Angew Chem Int Ed Engl; 2018 Oct; 57(41):13551-13554. PubMed ID: 30133094
[TBL] [Abstract][Full Text] [Related]
80. Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia.
Mastromarino P; Capobianco D; Cannata F; Nardis C; Mattia E; De Leo A; Restignoli R; Francioso A; Mosca L
Antiviral Res; 2015 Nov; 123():15-21. PubMed ID: 26296578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
